Savara, Inc. (SVRA)
5.20
-0.07
(-1.33%)
USD |
NASDAQ |
May 07, 10:59
Savara SG&A Expense (TTM) : 42.06M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 35.96M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Imunon, Inc. | 6.87M |